市場調査レポート

商品コード

バスキュラーアクセスデバイスの世界市場：タイプ別、挿入経路別、用途別、エンドユーザー別 - 予測（～2030年）

Vascular Access Devices Market by Type(Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral(Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User-Global Forecast to 2030

出版日: 2025年02月21日
発行: MarketsandMarkets
ページ情報: 英文 461 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,950 713,097円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (5-user License)

USD 6,650 957,999円

レポートPDFを同じ国内の同じ事業所内の5名迄にて共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 8,150 1,174,089円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 10,000 1,440,600円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバスキュラーアクセスデバイスの市場規模は、2024年の59億9,000万米ドルから2030年までに90億5,000万米ドルに達すると予測され、予測期間にCAGRで7.1%の成長が見込まれます。

調査範囲
調査対象年	2024年～2030年
基準年	2023年
予測期間	2024年～2030年
単位	米ドル
セグメント	タイプ、挿入経路、用途、エンドユーザー、地域
対象地域	北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

これは低侵襲手術の採用の増加によるものであり、採用が進むにつれてこれらのデバイスに対する需要が高まっています。さらに、医療向けインフラの建造に対する政府支援の増加により病院が増加し、結果としてバスキュラーアクセスデバイスの需要が増加しています。しかし、バスキュラーアクセスデバイスの交換やメンテナンスに関連する高いコストや製品のリコールの増加が市場の主な抑制要因となっています。さらに、訓練を受けた医療従事者の不足と製品に関する知識の乏しさは、市場成長への大きな課題です。しかし、2024年～2030年の予測期間では、市場拡大への環境が整いつつあります。

「タイプ別では、中心静脈アクセスデバイスセグメントが予測期間に最大のシェアを占めます。」

バスキュラーアクセスデバイス市場では、2023年に中心静脈アクセスデバイスセグメントが最大の市場シェアを占めました。これは、がんや慢性腎臓病などの慢性疾患の有病率が上昇しているためです。化学療法薬は強力であり、末梢ラインから投与すべきではないため、がん患者の大半はこれらの中心静脈アクセスデバイスを通じて化学療法を受けることになります。そのため、医療従事者の大半はこのデバイスを好んで使用しています。このように、これらの疾患の有病率が高まるにつれ、長期治療の必要性が高まり、その結果、バスキュラーアクセスデバイス市場の需要が増加しています。さらに、中心静脈アクセスデバイスは他のバスキュラーアクセスデバイスに比べて副作用が少ないため、このセグメントの成長に拍車をかけています。

「投薬セグメントが市場で最大のシェアを占めます。」

抗生物質治療、疼痛管理、化学療法など、長期の投薬を必要とする疾患での入院が増加しているため、投薬セグメントが最大の市場シェアを占めています。例えば、ある研究論文によると、がん患者の少なくとも25%は化学療法を受けており、そのため植込み型ポート、末梢挿入型中心静脈カテーテル、トンネル型カテーテルの需要が増加しています。さらに、血液透析に用いるトンネル型カテーテルの採用の増加も、市場成長を後押ししています。これらのデバイスは、代替品と比較して、デバイスを挿入するための事前処置を必要としないためです。

「地域別では、アジア太平洋が第2位の市場シェアを占めました。」

アジア太平洋はバスキュラーアクセスデバイス市場で2番目に大きな地域市場であり、予測期間にもっとも高いCAGRで成長する見込みです。これは、同地域全体で慢性疾患の有病率が増加し、高齢者が増加しているためです。例えば、Asia Development Bankによると、2050年までにアジア太平洋の4人に1人が60歳を超えると予測されており、このことが予測期間の市場成長に寄与しています。アジア太平洋には、日本、中国、インド、オーストラリア、韓国、その他のアジア太平洋が含まれます。このうち、中国は2023年に最大の市場シェアを占めました。これは、高齢者の増加、がん患者数の増加、病院の拡張が市場成長に寄与しているためです。例えば、CEICのデータによると、中国の病院数は2022年の36,976件から2023年に38,400件に増加しています。病院数の増加に伴い、患者を支援するバスキュラーアクセスデバイスへの需要も増加の一途をたどっています。

当レポートでは、世界のバスキュラーアクセスデバイス市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

バスキュラーアクセスデバイス市場の概要
北米のバスキュラーアクセスデバイス市場：エンドユーザー別、国別（2023年）
バスキュラーアクセスデバイス市場の地理的スナップショット（2023年）
地域構成：バスキュラーアクセスデバイス市場（2024年～2030年）
バスキュラーアクセスデバイス市場：新興市場 vs. 先進市場（2024年・2030年）

第5章市場の概要

イントロダクション
市場力学
- 促進要因
- 抑制要因
- 機会
- 課題
技術分析
- 主要技術
- 補完技術
- 隣接技術
産業動向
- 低侵襲バスキュラーアクセス手術
- カテーテル材料とコーティングの革新
バリューチェーン分析
エコシステム分析
サプライチェーン分析
貿易分析
- HSコード901839の輸入データ
- HSコード901839の輸出データ
ポーターのファイブフォース分析
主なステークホルダーと購入基準
規制分析
- 規制機関、政府機関、その他の組織
- 規制枠組み
特許分析
価格分析
- バスキュラーアクセスデバイスの価格動向：主要企業別（2021年～2023年）
- バスキュラーアクセスデバイスの価格動向：地域別（2021年～2023年）
主な会議とイベント（2025年～2026年）
隣接市場の分析
アンメットニーズ/エンドユーザーの期待
顧客のビジネスに影響を与える動向/混乱
投資と資金調達のシナリオ
バスキュラーアクセスデバイス市場に対するAI/生成AIの影響

第6章バスキュラーアクセスデバイス市場：タイプ別

イントロダクション
中心静脈アクセスデバイス
- 末梢挿入型中心静脈カテーテル
- トンネル型カテーテル
- 非トンネル型カテーテル
- 植込み型ポート
末梢血管アクセスデバイス
- 末梢静脈アクセスデバイス
- 末梢動脈アクセスデバイス
アクセサリ
骨内バスキュラーアクセスデバイス

第7章バスキュラーアクセスデバイス市場：挿入経路別

イントロダクション
静脈内挿入経路
皮下挿入経路
骨内挿入経路

第8章バスキュラーアクセスデバイス市場：用途別

イントロダクション
投薬
- 化学療法
- その他の投薬
水分と栄養の投与
輸血
診断・検査

第9章バスキュラーアクセスデバイス市場：エンドユーザー別

イントロダクション
病院
- 公立病院
- 私立病院
診療所・外来ケアセンター
その他のエンドユーザー

第10章バスキュラーアクセスデバイス市場：地域別

イントロダクション
北米
- 北米のマクロ経済の見通し
- 米国
- カナダ
欧州
- 欧州のマクロ経済の見通し
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他の欧州
アジア太平洋
- アジア太平洋のマクロ経済の見通し
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ラテンアメリカのマクロ経済の見通し
- ブラジル
- メキシコ
- その他のラテンアメリカ
中東・アフリカ
- 中東・アフリカのマクロ経済の見通し
- GCC諸国
- その他の中東・アフリカ

第11章競合情勢

イントロダクション
主要参入企業の戦略/強み
収益分析（2019年～2023年）
市場シェア分析（2023年）
企業の評価マトリクス：主要企業（2023年）
企業の評価マトリクス：スタートアップ/中小企業（2023年）
企業の評価と財務指標
ブランド/製品の比較
競合シナリオ

第12章企業プロファイル

主要企業
- BECTON, DICKINSON AND COMPANY
- TELEFLEX INCORPORATED
- ICU MEDICAL
- NIPRO
- ANGIODYNAMICS, INC.
- VYGON
- TERUMO CORPORATION
- MEDTRONIC PLC
- COOK
- B. BRAUN SE
- MERIT MEDICAL SYSTEMS, INC.
- AMECATH
- MEDICAL COMPONENTS, INC.
- HEALTHLINE MEDICAL PRODUCTS
- ACCESS VASCULAR, INC.
その他の企業
- ARGON MEDICAL DEVICES
- PAKUMEDMEDICAL PRODUCTS GMBH
- GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
- PFM MEDICAL GMBH
- MEDI-TECH DEVICES PVT. LTD.
- KIMAL
- POLYMEDICURE
- DELTAMED
- NEWTECH MEDICAL DEVICES PVT. LTD.
- SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

第13章付録

図表

List of Tables

TABLE 1 VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS
TABLE 4 VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS
TABLE 5 VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 6 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 7 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 8 VASCULAR ACCESS DEVICES MARKET: PORTER'S FIVE FORCES
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
TABLE 10 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021-2023
TABLE 17 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021-2023
TABLE 18 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
TABLE 19 VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 20 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 21 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 22 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 23 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 24 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 25 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 26 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 27 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 28 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 29 TUNNELED CATHETERS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 30 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 31 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 32 IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 33 IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 34 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 35 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 36 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 37 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 38 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 39 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 40 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 41 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 42 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 43 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 44 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 45 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 46 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 47 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 48 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 49 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 50 MIDLINE CATHETERS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 51 MIDLINE CATHETERS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 52 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 53 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 54 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 55 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 56 ACCESSORIES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 57 ACCESSORIES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 58 INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 59 INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 60 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 61 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 62 VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 63 VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 64 VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 65 VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 66 VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 67 VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 68 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 69 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 70 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 71 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 72 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 73 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 74 VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 75 VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 76 VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 77 VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 78 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 79 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 80 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 81 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 82 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 83 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 84 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 85 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 86 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 87 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 88 PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 89 PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 90 PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 91 PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 92 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 93 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 94 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 95 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 96 VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 97 VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024-2030 (USD MILLION)
TABLE 98 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2030 (THOUSAND UNITS)
TABLE 99 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 100 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 101 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 102 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 104 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 106 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 108 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 110 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 112 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 113 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 114 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 116 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 118 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 119 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 120 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121 US: KEY MACROINDICATORS
TABLE 122 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 123 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 124 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 125 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 126 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 127 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 128 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 129 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 130 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 131 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 132 US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 133 US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 134 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 135 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 136 US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 137 US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 138 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 139 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 140 US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 141 US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 142 CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022-2024
TABLE 143 CANADA: KEY MACROINDICATORS
TABLE 144 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 145 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 146 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 147 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 148 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 149 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 150 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 151 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 152 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 153 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 154 CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 155 CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 156 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 157 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 158 CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 159 CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 160 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 161 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 162 CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 163 CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 164 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 165 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 166 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 167 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 168 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 169 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 170 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 171 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 172 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 173 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 174 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 175 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 176 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 177 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 178 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 179 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 180 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 181 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 182 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 183 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 184 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 185 EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 186 GERMANY: KEY MACROINDICATORS
TABLE 187 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 188 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 190 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 192 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 194 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 196 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 198 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 199 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 200 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 202 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 204 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 205 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 206 GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207 UK: KEY MACROINDICATORS
TABLE 208 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 209 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 210 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 211 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 212 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 213 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 214 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 215 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 216 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 217 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 218 UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 219 UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 220 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 221 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 222 UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 223 UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 224 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 225 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 226 UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 227 UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 228 FRANCE: KEY MACROINDICATORS
TABLE 229 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 230 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 232 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 234 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 236 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 238 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 240 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 241 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 242 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 244 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 246 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 247 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 248 FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249 ITALY: KEY MACROINDICATORS
TABLE 250 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 251 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 252 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 253 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 254 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 255 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 256 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 257 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 258 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 259 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 260 ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 261 ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 262 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 263 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 264 ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 265 ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 266 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 267 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 268 ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 269 ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 270 SPAIN: KEY MACROINDICATORS
TABLE 271 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 272 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 274 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 276 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 278 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279 SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 280 SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 282 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 283 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 284 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 286 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 288 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 289 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 290 SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 291 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 292 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293 REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 294 REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295 REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 296 REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 297 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 298 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 299 REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 300 REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 301 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 302 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 303 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 304 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 305 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 306 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 307 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 308 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 309 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 310 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 311 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 312 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 313 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 314 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 315 ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 316 ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 317 ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 318 ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 319 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 320 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321 ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 322 ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 323 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 324 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 325 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 326 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 328 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 329 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 330 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 331 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 332 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 333 CHINA: KEY MACROINDICATORS
TABLE 334 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 335 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 336 CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 337 CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 338 CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 339 CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 340 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 341 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 342 CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 343 CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 344 CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 345 CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 346 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 347 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 348 CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 349 CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 350 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 351 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 352 CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 353 CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 354 INDIA: KEY MACROINDICATORS
TABLE 355 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 356 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 357 INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 358 INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 359 INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 360 INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 361 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 362 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 363 INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 364 INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 365 INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 366 INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 367 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 368 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 369 INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 370 INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 371 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 372 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 373 INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 374 INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 375 JAPAN: KEY MACROINDICATORS
TABLE 376 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 377 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 378 JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 379 JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 380 JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 381 JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 382 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 383 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 384 JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 385 JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 386 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 387 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 388 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 389 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 390 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 391 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 392 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 393 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 394 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 395 JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 396 AUSTRALIA: KEY MACROINDICATORS
TABLE 397 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 398 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 399 AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 400 AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 401 AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 402 AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 403 AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 404 AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 405 AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 406 AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 407 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 408 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 409 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 410 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 411 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 412 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 413 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 414 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 415 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 416 AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 417 SOUTH KOREA: KEY MACROINDICATORS
TABLE 418 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 419 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 420 SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 421 SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 422 SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 423 SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 424 SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 425 SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 426 SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 427 SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 428 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 429 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 430 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 431 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 432 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 433 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 434 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 435 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 436 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 437 SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 438 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 439 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 440 REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 441 REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 447 REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 448 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 449 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 450 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 451 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 452 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 453 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 454 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 455 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 456 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 457 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 458 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
TABLE 459 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 460 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 461 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 462 LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 463 LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 464 LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 465 LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 466 LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 467 LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 468 LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 469 LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 470 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 471 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 472 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 473 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 474 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 475 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 476 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 477 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 478 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 479 LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 480 BRAZIL: KEY MACROINDICATORS
TABLE 481 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 482 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 483 BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 484 BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 485 BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 486 BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 487 BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 488 BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 489 BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 490 BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 491 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 492 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 493 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 494 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 495 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 496 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 497 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 498 BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 499 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 500 BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 501 MEXICO: KEY MACROINDICATORS
TABLE 502 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 503 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 504 MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 505 MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 506 MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 507 MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 508 MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 509 MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 510 MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 511 MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 512 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 513 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 514 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 515 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 516 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 517 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 518 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 519 MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 520 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 521 MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 522 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 523 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 524 REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 525 REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 526 REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 527 REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 528 REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 529 REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 530 REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 531 REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 532 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 533 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 534 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 535 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 536 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 537 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 538 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 539 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 540 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 541 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 542 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021-2023 (USD MILLION)
TABLE 543 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2024-2030 (USD MILLION)
TABLE 544 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 545 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 546 MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 547 MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 548 MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 549 MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 550 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 551 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 552 MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 553 MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 554 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 555 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 556 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 557 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 558 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 559 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 560 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 561 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 562 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 563 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 564 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 565 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 566 GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 567 GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 568 GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 569 GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 570 GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 571 GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 572 GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 573 GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 574 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 575 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 576 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 577 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 578 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 579 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 580 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 581 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 582 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 583 GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 584 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 585 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 586 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 587 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 588 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 589 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 590 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 591 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 592 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021-2023 (USD MILLION)
TABLE 593 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2030 (USD MILLION)
TABLE 594 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021-2023 (USD MILLION)
TABLE 595 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024-2030 (USD MILLION)
TABLE 596 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
TABLE 597 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 598 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021-2023 (USD MILLION)
TABLE 599 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2030 (USD MILLION)
TABLE 600 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021-2023 (USD MILLION)
TABLE 601 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024-2030 (USD MILLION)
TABLE 602 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021-2023 (USD MILLION)
TABLE 603 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2030 (USD MILLION)
TABLE 604 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
TABLE 605 VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION
TABLE 606 VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT
TABLE 607 VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT
TABLE 608 VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT
TABLE 609 VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT
TABLE 610 VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT
TABLE 611 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 612 VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 613 VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 614 VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021-JANUARY 2025
TABLE 615 VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 616 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 617 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 618 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-JANUARY 2025
TABLE 619 TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 620 TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 621 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 622 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 623 ICU MEDICAL: COMPANY OVERVIEW
TABLE 624 ICU MEDICAL: PRODUCTS OFFERED
TABLE 625 ICU MEDICAL: DEALS, JANUARY 2021-JANUARY 2025
TABLE 626 NIPRO: COMPANY OVERVIEW
TABLE 627 NIPRO: PRODUCTS OFFERED
TABLE 628 ANGIODYNAMICS, INC.: COMPANY OVERVIEW
TABLE 629 ANGIODYNAMICS, INC.: PRODUCTS OFFERED
TABLE 630 ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 631 ANGIODYNAMICS, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 632 VYGON: COMPANY OVERVIEW
TABLE 633 VYGON: PRODUCTS OFFERED
TABLE 634 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 635 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 636 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 637 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 638 COOK: COMPANY OVERVIEW
TABLE 639 COOK: PRODUCTS OFFERED
TABLE 640 B. BRAUN SE: COMPANY OVERVIEW
TABLE 641 B. BRAUN SE: PRODUCTS OFFERED
TABLE 642 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 643 B. BRAUN SE: DEALS, JANUARY 2021-JANUARY 2025
TABLE 644 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 645 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 646 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 647 AMECATH: COMPANY OVERVIEW
TABLE 648 AMECATH: PRODUCTS OFFERED
TABLE 649 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
TABLE 650 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
TABLE 651 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
TABLE 652 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
TABLE 653 ACCESS VASCULAR, INC.: COMPANY OVERVIEW
TABLE 654 ACCESS VASCULAR, INC.: PRODUCTS OFFERED
TABLE 655 ARGON MEDICAL DEVICES: COMPANY OVERVIEW
TABLE 656 PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
TABLE 657 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 658 PFM MEDICAL GMBH: COMPANY OVERVIEW
TABLE 659 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 660 KIMAL: COMPANY OVERVIEW
TABLE 661 POLYMEDICURE: COMPANY OVERVIEW
TABLE 662 DELTAMED: COMPANY OVERVIEW
TABLE 663 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 664 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW

List of Figures

FIGURE 1 VASCULAR ACCESS DEVICES MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
FIGURE 2 VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED
FIGURE 3 VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN
FIGURE 4 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5 VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES
FIGURE 6 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7 VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 9 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 10 VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 11 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS
FIGURE 12 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET
FIGURE 13 VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS
FIGURE 14 VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION
FIGURE 15 CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 16 TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030
FIGURE 17 IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD
FIGURE 18 PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 19 PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 20 INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030
FIGURE 21 DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT
FIGURE 22 CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
FIGURE 23 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 24 PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD
FIGURE 25 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES
FIGURE 26 RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET
FIGURE 27 US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023
FIGURE 28 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 29 ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030
FIGURE 30 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 31 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 32 VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 33 VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 34 VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 35 VASCULAR ACCESS DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES
FIGURE 38 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014-DECEMBER 2024)
FIGURE 39 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014-DECEMBER 2024)
FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014- DECEMBER 2024)
FIGURE 41 VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW
FIGURE 42 VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
FIGURE 43 VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2019-2023
FIGURE 44 VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI
FIGURE 45 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 46 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
FIGURE 47 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019-2023)
FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)
FIGURE 50 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 51 VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 52 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 53 EV/EBITDA OF KEY VENDORS
FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 55 VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 56 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
FIGURE 58 ICU MEDICAL: COMPANY SNAPSHOT
FIGURE 59 NIPRO: COMPANY SNAPSHOT
FIGURE 60 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
FIGURE 61 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 62 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 63 B. BRAUN SE: COMPANY SNAPSHOT
FIGURE 64 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT

Product Code: MD 5434

The global Vascular access device market is projected to reach USD 9.05 billion by 2030 from USD 5.99 billion in 2024, at a CAGR of 7.1% during the forecast period.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2023
Forecast Period	2024-2030
Units Considered	Value (USD)
Segments	Type, Route of Insertion, Application, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (GCC Countries, RoMEA)

This is due to increasing adoption of minimally invasive procedure, as the adoption increases the demand for these devices rises. Additionally, increasing government support to build infrastructure for healthcare is increasing, thus rising the number of hospitals, consequently increasing the demand for the vascular access device. However, the high cost associated with replacement and maintenance of vascular access devices and increasing product recalls are the major restraint to the market. Additionally, the shortage of trained healthcare professionals & limited knowledge about the products is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030.

"The central venous access device segment of vascular access device market by type to hold largest position forecast period."

Based on the product, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous access device, and accessories. Among these, in 2023 central venous access device segment account for the largest market share of XX% in vascular access device market. This is due to the rising prevalence of chronic diseases such as cancer, chronic kidney disease. Majority of the cancer patients will be given chemotherapy through these central venous access devices, as the chemotherapy drug are potent and should not be given through peripheral line. Thus, majority of the healthcare professionals prefer these devices. Thus, as the prevalence of these diseases is increasing the need for long-term treatment is rising, consequently increasing the demand for vascular access device market. Additionally, central venous access device has lesser adverse reactions compared to other vascular access devices thus fueling the segmental growth.

"The drug administration segment accounts for the largest market share in vascular access device market."

Based on application, the vascular access device market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment accounts for the largest market share in vascular access device market due to increasing hospitalization for diseases which require long term drug administration such as antibiotic therapy, pain management, chemotherapy and others. For instance, as per a research article, at least 25% of cancer patients undergo chemotherapy, thus increasing demand for implantable ports, peripherally inserted central catheters and tunneled catheters. Additionally, increasing adoption of tunneled catheters for hemodialysis is supporting the market growth, as these devices does not require any prior procedure to insert the device compared to their alternatives. This segment is again divided into chemotherapy and other drug administration. Among these, in 2023, other drug administration segment to hold the largest market share of XX% in vascular access device market by drug application. This is due to increased prevalence of diseases such as infectious diseases, chronic inflammatory diseases, cardiovascular diseases and among others.

"Asia Pacific accounted for the second largest share of the vascular access device market by region."

The global vascular access device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the second largest regional market for vascular access device equipment and is estimated to grow at the highest CAGR during the forecast period. This is due to increasing prevalence of chronic diseases and rising geriatric population across the region. For instance, as per Asia Development Bank, by 2050, one in four people in Asia and Pacific will be over 60 years old thus contributing to the market growth across the forecast period. Asia Pacific region includes Japan, China, India, Australia, South Korea and Rest of Asia Pacific. Among these, China accounts for the largest market share in vascular access device market in 2023. This is due to increasing aging population and rising number of cancer cases and hospital expansions contribute to the growing market. For instance, as per CEIC data, number of hospitals in China increased from 36,976 in 2022 to 38400 in 2023. As the number of hospitals increases, the demand for vascular access devices continues to grow, to support patients.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
By Designation: C-level-50%, Director-level-30% and Others-20%
By Region: North America-30%, Europe-25%, Asia Pacific-20%, Latin America- 15%, and Middle east and Africa - 10%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the vascular access device market are Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), Healtline Medical Products (US), Cook (US), and Access Vascular, Inc. (US)

Research Coverage

This report studies the vascular access device market based on product, type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analysis of Key divers (Growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, growing use of vascular access devices in pediatric patients), restraints (High cost associated with placement and maintenance of vascular access device, product recalls and failures), Challenge (Shortage of skilled professionals, risks associated with vascular access devices), opportunity (Technological Advancements, growth in number of hospitals)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the vascular access device market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the vascular access device market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Objectives of secondary research
  - 2.1.1.2 Key secondary sources
  - 2.1.1.3 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key primary sources
  - 2.1.2.2 Key objectives of primary research
  - 2.1.2.3 Key data from primary sources
  - 2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
- 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
- 2.2.2 TOP-DOWN APPROACH
- 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
- 2.2.4 DEMAND-SIDE ANALYSIS
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 MARKET RANKING ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW
4.2 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER AND COUNTRY, 2023
4.3 GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET, 2023
4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET, 2024-2030 (USD MILLION)
4.5 VASCULAR ACCESS DEVICES MARKET: EMERGING VS. DEVELOPED MARKETS, 2024 VS. 2030 (USD MILLION)

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing prevalence of lifestyle diseases
  - 5.2.1.2 Increasing popularity of chemotherapy procedures among cancer patients
  - 5.2.1.3 Rising use of vascular access devices among pediatric patients
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of installation and maintenance of vascular access devices
  - 5.2.2.2 Rising product recalls and failures
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Technological advancements
  - 5.2.3.2 Increasing number of hospitals and expanding patient pool
- 5.2.4 CHALLENGES
  - 5.2.4.1 Shortage of skilled healthcare professionals
  - 5.2.4.2 Risks associated with use of vascular access devices
5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
  - 5.3.1.1 Imaging and navigation technologies
  - 5.3.1.2 Catheter securement and stabilization technologies
- 5.3.2 COMPLEMENTARY TECHNOLOGIES
  - 5.3.2.1 AI and ML
- 5.3.3 ADJACENT TECHNOLOGIES
  - 5.3.3.1 Infection control technologies
5.4 INDUSTRY TRENDS
- 5.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
- 5.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
- 5.6.1 ROLE IN ECOSYSTEM
5.7 SUPPLY CHAIN ANALYSIS
5.8 TRADE ANALYSIS
- 5.8.1 IMPORT DATA FOR HS CODE 901839
- 5.8.2 EXPORT DATA FOR HS CODE 901839
5.9 PORTER'S FIVE FORCES ANALYSIS
- 5.9.1 THREAT OF NEW ENTRANTS
- 5.9.2 THREAT OF SUBSTITUTES
- 5.9.3 BARGAINING POWER OF BUYERS
- 5.9.4 BARGAINING POWER OF SUPPLIERS
- 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.10.2 KEY BUYING CRITERIA
5.11 REGULATORY ANALYSIS
- 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.11.2 REGULATORY FRAMEWORK
  - 5.11.2.1 North America
    - 5.11.2.1.1 US
    - 5.11.2.1.2 Canada
  - 5.11.2.2 Europe
  - 5.11.2.3 Asia Pacific
  - 5.11.2.4 Latin America
  - 5.11.2.5 Middle East & Africa
5.12 PATENT ANALYSIS
- 5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13 PRICING ANALYSIS
- 5.13.1 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021-2023
- 5.13.2 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021-2023
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 ADJACENT MARKET ANALYSIS
- 5.15.1 VASCULAR CLOSURE DEVICES MARKET
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET

6 VASCULAR ACCESS DEVICES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 CENTRAL VENOUS ACCESS DEVICES
- 6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS
  - 6.2.1.1 Better durability and increased clinical utility for extended treatment plans to drive segment
- 6.2.2 TUNNELED CATHETERS
  - 6.2.2.1 Lower risk of infection and superior longevity to support segment growth
- 6.2.3 NON-TUNNELED CATHETERS
  - 6.2.3.1 Non-tunneled catheters to be used in critical cases with limited peripheral access
- 6.2.4 IMPLANTABLE PORTS
  - 6.2.4.1 Implantable conventional ports
    - 6.2.4.1.1 Ability to provide reliable venous access with minimal maintenance to spur adoption
  - 6.2.4.2 Implantable power injectable ports
    - 6.2.4.2.1 Ability to accommodate high-flow fluids and increased demand for chemotherapy to propel market growth
6.3 PERIPHERAL VASCULAR ACCESS DEVICES
- 6.3.1 PERIPHERAL VENOUS ACCESS DEVICES
  - 6.3.1.1 Peripheral intravenous catheters
    - 6.3.1.1.1 Cost-effectiveness, ease of placement, and compatibility with different treatments to augment segment growth
  - 6.3.1.2 Midline catheters
    - 6.3.1.2.1 Ability to provide reliable medium-term intravenous access from one to four weeks to aid segment growth
  - 6.3.1.3 Butterfly/Winged steel needles
    - 6.3.1.3.1 Precision and comfort in short-term venous access procedures to drive segment
- 6.3.2 PERIPHERAL ARTERIAL ACCESS DEVICES
  - 6.3.2.1 Critical role in continuous hemodynamic monitoring and blood sampling in acute care settings to propel segment growth
6.4 ACCESSORIES
- 6.4.1 NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET
6.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES
- 6.5.1 CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES

7 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION

7.1 INTRODUCTION
7.2 INTRAVENOUS ROUTE OF INSERTION
- 7.2.1 RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH
7.3 SUBCUTANEOUS ROUTE OF INSERTION
- 7.3.1 REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH
7.4 INTRAOSSEOUS ROUTE OF INSERTION
- 7.4.1 NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES TO FUEL UPTAKE

8 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 DRUG ADMINISTRATION
- 8.2.1 CHEMOTHERAPY
  - 8.2.1.1 Increased incidence of cancer and advancements in oncology care to drive segment
- 8.2.2 OTHER DRUG ADMINISTRATION
8.3 FLUID & NUTRITION ADMINISTRATION
- 8.3.1 INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH
8.4 BLOOD TRANSFUSION
- 8.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH
8.5 DIAGNOSTICS & TESTING
- 8.5.1 INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH

9 VASCULAR ACCESS DEVICES MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS
- 9.2.1 PUBLIC HOSPITALS
  - 9.2.1.1 Increasing demand for affordable healthcare services in emerging economies to drive segment
- 9.2.2 PRIVATE HOSPITALS
  - 9.2.2.1 Rising demand for advanced healthcare services and high-quality treatment options to drive market
9.3 CLINICS & AMBULATORY CARE CENTERS
- 9.3.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH
9.4 OTHER END USERS

10 VASCULAR ACCESS DEVICES MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 US to dominate North American vascular access devices market during forecast period
- 10.2.3 CANADA
  - 10.2.3.1 Rising cancer prevalence and advanced research initiatives to propel market growth
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 Rising obesity rates and growing geriatric population to augment market growth
- 10.3.3 UK
  - 10.3.3.1 Increased disease burden to fuel uptake for advanced vascular access devices for better treatment procedures
- 10.3.4 FRANCE
  - 10.3.4.1 Presence of vascular access device manufacturers and technological advancements to fuel market growth
- 10.3.5 ITALY
  - 10.3.5.1 Strong government healthcare policies to boost market growth
- 10.3.6 SPAIN
  - 10.3.6.1 Growing geriatric population and rising incidence of chronic diseases to fuel market growth
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 Advanced healthcare infrastructure and high geriatric population to support market growth
- 10.4.3 INDIA
  - 10.4.3.1 Rising governmental health expenditure and increasing incidence of chronic diseases to fuel market growth
- 10.4.4 JAPAN
  - 10.4.4.1 Increased geriatric population and high prevalence of cancer to drive market
- 10.4.5 AUSTRALIA
  - 10.4.5.1 Increased demand for hemodialysis and advancements in healthcare infrastructure to propel market growth
- 10.4.6 SOUTH KOREA
  - 10.4.6.1 Rising burden of chronic diseases and increasing aged population to boost market growth
- 10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Growing cancer burden and rising need for long-term treatment for chronic patients to drive market
- 10.5.3 MEXICO
  - 10.5.3.1 Increasing focus on dialysis for patients with chronic kidney diseases to drive adoption of advanced vascular access devices
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
  - 10.6.2.1 Increasing healthcare investments and rising prevalence of chronic diseases to propel market growth
- 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
11.3 REVENUE ANALYSIS, 2019-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 11.5.5.1 Company footprint
  - 11.5.5.2 Region footprint
  - 11.5.5.3 Type footprint
  - 11.5.5.4 Route of insertion footprint
  - 11.5.5.5 Application footprint
  - 11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 11.6.5.1 Detailed list of key startup/SME players
  - 11.6.5.2 Competitive benchmarking of key emerging players/startups
11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES & APPROVALS
- 11.9.2 DEALS
- 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

12.1 KEY PLAYERS
- 12.1.1 BECTON, DICKINSON AND COMPANY
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Deals
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Key strengths
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 TELEFLEX INCORPORATED
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products offered
  - 12.1.2.3 Recent developments
    - 12.1.2.3.1 Product launches
    - 12.1.2.3.2 Other developments
  - 12.1.2.4 MnM view
    - 12.1.2.4.1 Key strengths
    - 12.1.2.4.2 Strategic choices
    - 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 ICU MEDICAL
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products offered
  - 12.1.3.3 Recent developments
    - 12.1.3.3.1 Deals
  - 12.1.3.4 MnM view
    - 12.1.3.4.1 Key strengths
    - 12.1.3.4.2 Strategic choices
    - 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 NIPRO
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products offered
  - 12.1.4.3 MnM view
    - 12.1.4.3.1 Key strengths
    - 12.1.4.3.2 Strategic choices
    - 12.1.4.3.3 Weaknesses & competitive threats
- 12.1.5 ANGIODYNAMICS, INC.
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products offered
  - 12.1.5.3 Recent developments
    - 12.1.5.3.1 Product approvals
    - 12.1.5.3.2 Deals
  - 12.1.5.4 MnM view
    - 12.1.5.4.1 Key strengths
    - 12.1.5.4.2 Strategic choices
    - 12.1.5.4.3 Weaknesses & competitive threats
- 12.1.6 VYGON
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products offered
- 12.1.7 TERUMO CORPORATION
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products offered
- 12.1.8 MEDTRONIC PLC
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products offered
- 12.1.9 COOK
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products offered
- 12.1.10 B. BRAUN SE
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products offered
  - 12.1.10.3 Recent developments
    - 12.1.10.3.1 Product launches & approvals
    - 12.1.10.3.2 Deals
- 12.1.11 MERIT MEDICAL SYSTEMS, INC.
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products offered
  - 12.1.11.3 Recent developments
    - 12.1.11.3.1 Deals
- 12.1.12 AMECATH
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products offered
- 12.1.13 MEDICAL COMPONENTS, INC.
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products offered
- 12.1.14 HEALTHLINE MEDICAL PRODUCTS
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products offered
- 12.1.15 ACCESS VASCULAR, INC.
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products offered
12.2 OTHER PLAYERS
- 12.2.1 ARGON MEDICAL DEVICES
- 12.2.2 PAKUMEDMEDICAL PRODUCTS GMBH
- 12.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
- 12.2.4 PFM MEDICAL GMBH
- 12.2.5 MEDI-TECH DEVICES PVT. LTD.
- 12.2.6 KIMAL
- 12.2.7 POLYMEDICURE
- 12.2.8 DELTAMED
- 12.2.9 NEWTECH MEDICAL DEVICES PVT. LTD.
- 12.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

バスキュラーアクセスデバイスの世界市場：タイプ別、挿入経路別、用途別、エンドユーザー別 - 予測（～2030年）

Vascular Access Devices Market by Type(Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral(Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User-Global Forecast to 2030

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場の概要

第6章バスキュラーアクセスデバイス市場：タイプ別

第7章バスキュラーアクセスデバイス市場：挿入経路別

第8章バスキュラーアクセスデバイス市場：用途別

第9章バスキュラーアクセスデバイス市場：エンドユーザー別

第10章バスキュラーアクセスデバイス市場：地域別

第11章競合情勢

第12章企業プロファイル

第13章付録

List of Tables

List of Figures

A breakdown of the primary participants referred to for this report is provided below:

This report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 VASCULAR ACCESS DEVICES MARKET, BY TYPE

7 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION

8 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

9 VASCULAR ACCESS DEVICES MARKET, BY END USER

10 VASCULAR ACCESS DEVICES MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

バスキュラーアクセスデバイスの世界市場：タイプ別、挿入経路別、用途別、エンドユーザー別 - 予測（～2030年）

Vascular Access Devices Market by Type(Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral(Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User-Global Forecast to 2030

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場の概要

第6章 バスキュラーアクセスデバイス市場：タイプ別

第7章 バスキュラーアクセスデバイス市場：挿入経路別

第8章 バスキュラーアクセスデバイス市場：用途別

第9章 バスキュラーアクセスデバイス市場：エンドユーザー別

第10章 バスキュラーアクセスデバイス市場：地域別

第11章 競合情勢

第12章 企業プロファイル

第13章 付録

List of Tables

List of Figures

A breakdown of the primary participants referred to for this report is provided below:

This report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 VASCULAR ACCESS DEVICES MARKET, BY TYPE

7 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION

8 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

9 VASCULAR ACCESS DEVICES MARKET, BY END USER

10 VASCULAR ACCESS DEVICES MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場の概要

第6章バスキュラーアクセスデバイス市場：タイプ別

第7章バスキュラーアクセスデバイス市場：挿入経路別

第8章バスキュラーアクセスデバイス市場：用途別

第9章バスキュラーアクセスデバイス市場：エンドユーザー別

第10章バスキュラーアクセスデバイス市場：地域別

第11章競合情勢

第12章企業プロファイル

第13章付録